2017
DOI: 10.1371/journal.pone.0180443
|View full text |Cite
|
Sign up to set email alerts
|

Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia

Abstract: ObjectiveUse of oral short-acting beta 2-agonist (SABA) persists in non-resource poor countries despite concerns for its lower efficacy and safety. Utilisation and reasons for such use is needed to support the effort to discourage the use of oral SABA in asthma. This study examined the frequency of oral short-acting Beta 2-agonist (SABA) usage in the management of asthma in primary care and determined correlates of its usage.MethodsData used were from the 2014 National Medical Care Survey in Malaysia, a nation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 22 publications
0
5
0
Order By: Relevance
“…Although in the present study, the proportion of patients who used inhaled corticosteroids (ICS), long-acting inhaled β 2 -agonist (LABA) and/or oral short-acting β 2 -agonist were non-significantly higher in the uncontrolled asthma than in the controlled asthma group, being on treatment has a significant association with uncontrolled asthma. Moreover, in our patient cohort, as common in low-income countries, short-acting β 2 -agonist (SABA) was the most frequent form of treatment even though it has lower efficacy and safety [48].…”
Section: Discussionmentioning
confidence: 99%
“…Although in the present study, the proportion of patients who used inhaled corticosteroids (ICS), long-acting inhaled β 2 -agonist (LABA) and/or oral short-acting β 2 -agonist were non-significantly higher in the uncontrolled asthma than in the controlled asthma group, being on treatment has a significant association with uncontrolled asthma. Moreover, in our patient cohort, as common in low-income countries, short-acting β 2 -agonist (SABA) was the most frequent form of treatment even though it has lower efficacy and safety [48].…”
Section: Discussionmentioning
confidence: 99%
“…Less than half of adult asthma patients had regular long-term follow-up [9][10][11] . In addition, studies have reported under-utilisation of controller medications 10,11 , while the use of oral short-acting beta-agonist was common among adults with poor asthma control in Malaysia [10][11][12] .…”
Section: Introductionmentioning
confidence: 99%
“…A high level of preventer prescription was also observed in this study whereby 89.8 percent of patients with poor control asthma were prescribed with inhaled corticosteroid or LABA or both. These levels of prescription were not far off the 100 percent standard targets and they were substantially higher than those in a national study done at both public and private primary care clinics in Malaysia [16]. In the latter study, 50.2 and 38.3 percent of 9241 asthmatic patients were prescribed with inhaled SABA and a preventer, respectively.…”
mentioning
confidence: 64%